Rubio Daniel R, Clohisy John C F, Gupta Munish C, Lenke Lawrence G, Kelly Michael P
1Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut.
2Department of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri.
Neurosurg Focus. 2025 Jun 1;58(6):E3. doi: 10.3171/2025.3.FOCUS2575.
The Decision Regret Scale (DRS) is a valid instrument evaluating the "correctness" of a treatment decision from the patient perspective. The minimal clinically important difference (MCID) is proposed as a threshold for patient-reported outcome measure (PROM) improvement success. The relationship between decision regret and failure to achieve clinical success in adult spinal deformity (ASD) surgeries is not known. The authors sought to examine the relationships between the DRS and outcomes, as measured by the Scoliosis Research Society-22r (SRS-22r), in ASD surgery.
ASD patients with a minimum 2-year follow-up completed the DRS and SRS-22r questionnaires. Records were reviewed for complications and revision surgeries. SRS-22r domain scores were dichotomized as successful or not by MCID values. Patients with DRS scores of 0-20 were defined as having no decision regret. Relationships between DRS and SRS-22r domain scores were explored, as were relationships between DRS and complication/revision surgery.
A total of 46 patients met inclusion criteria. The average age was 64 years, and the average follow-up was 4.3 years (range 2.0-15.5 years). The mean DRS score was 7.6 with a median score of 0; 15% (7/46) expressed decision regret. Worse SRS-22r pain (p = 0.049), function (p = 0.03), and satisfaction (p = 0.006) were associated with higher DRS scores. Rates of decision regret were not different between those achieving MCID and those who did not (pain, p = 0.1; function, p = 0.1; self-image, p = 0.4; and subscore p = 0.09). There was no difference in the number of patients with decision regret in terms of postoperative complications or patients requiring revision surgery and those who did not.
Decision regret after ASD surgeries was uncommon despite complications, reoperations, and failure to achieve MCID changes in SRS-22r domains. Worse SRS-22r pain, function, and satisfaction scores were associated with more decision regret, however.
决策后悔量表(DRS)是一种从患者角度评估治疗决策“正确性”的有效工具。最小临床重要差异(MCID)被提议作为患者报告结局指标(PROM)改善成功的阈值。成人脊柱畸形(ASD)手术中决策后悔与未取得临床成功之间的关系尚不清楚。作者试图研究在ASD手术中DRS与结局(通过脊柱侧凸研究学会22r问卷(SRS - 22r)测量)之间的关系。
对至少随访2年的ASD患者进行DRS和SRS - 22r问卷调查。查阅记录以了解并发症和翻修手术情况。SRS - 22r领域得分根据MCID值分为成功或不成功。DRS得分0 - 20分的患者被定义为无决策后悔。探讨了DRS与SRS - 22r领域得分之间的关系,以及DRS与并发症/翻修手术之间的关系。
共有46例患者符合纳入标准。平均年龄为64岁,平均随访时间为4.3年(范围2.0 - 15.5年)。DRS平均得分为7.6分,中位数为0分;15%(7/46)表示有决策后悔。SRS - 22r疼痛(p = 0.049)、功能(p = 0.03)和满意度(p = 0.006)较差与较高的DRS得分相关。达到MCID的患者和未达到MCID的患者之间的决策后悔率没有差异(疼痛,p = 0.1;功能,p = 0.1;自我形象,p = 0.4;总分,p = 0.09)。在有决策后悔的患者数量方面,术后有并发症或需要翻修手术的患者与未出现这些情况的患者之间没有差异。
尽管存在并发症、再次手术以及SRS - 22r领域未实现MCID变化,但ASD手术后的决策后悔并不常见。然而,SRS - 22r疼痛、功能和满意度得分越差,决策后悔就越多。